Heart Attack, Avandia | featured news

Diabetes pill Avandia to be severely restricted

Diabetes pill Avandia to be severely restricted

U.S. government health regulators will allow GlaxoSmithKline to continue selling a controversial diabetes pill but will restrict access to the once-blockbuster drug because of heart attack risks.

 

Subscribe to this RSS topic: Syndicate content